Reed E - Search Results

1

A phase I trial of carboxyamido-triazole and paclitaxel for relapsed solid tumors: potential efficacy of the combination and demonstration of pharmacokinetic interaction.

Kohn EC, Reed E, Sarosy GA, Minasian L, Bauer KS, Bostick-Bruton F, Kulpa V, Fuse E, Tompkins A, Noone M, Goldspiel B, Pluda J, Figg WD, Liotta LA. Kohn EC, et al. Among authors: reed e. Clin Cancer Res. 2001 Jun;7(6):1600-9. Clin Cancer Res. 2001. PMID: 11410496 Clinical Trial.

2

Ormaplatin sensitivity/resistance in human ovarian cancer cells made resistant to cisplatin.

Parker RJ, Vionnet JA, Bostick-Bruton F, Reed E. Parker RJ, et al. Among authors: reed e. Cancer Res. 1993 Jan 15;53(2):242-7. Cancer Res. 1993. PMID: 8417816

3

Clinical investigation of a cytostatic calcium influx inhibitor in patients with refractory cancers.

Kohn EC, Reed E, Sarosy G, Christian M, Link CJ, Cole K, Figg WD, Davis PA, Jacob J, Goldspiel B, Liotta LA. Kohn EC, et al. Among authors: reed e. Cancer Res. 1996 Feb 1;56(3):569-73. Cancer Res. 1996. PMID: 8564973 Clinical Trial.

4

A phase I study of paclitaxel and cyclophosphamide in recurrent adenocarcinoma of the ovary.

Reed E, Sarosy G, Kohn E, Christian M, Link CJ Jr, Goldspiel B, Davis P, Jacob J, Maher M. Reed E, et al. Gynecol Oncol. 1996 Jun;61(3):349-53. doi: 10.1006/gyno.1996.0155. Gynecol Oncol. 1996. PMID: 8641614 Clinical Trial.

5

Paclitaxel dose intensity.

Reed E, Bitton R, Sarosy G, Kohn E. Reed E, et al. J Infus Chemother. 1996 Spring;6(2):59-63. J Infus Chemother. 1996. PMID: 8809650 Review.

6

Phase I trial of micronized formulation carboxyamidotriazole in patients with refractory solid tumors: pharmacokinetics, clinical outcome, and comparison of formulations.

Kohn EC, Figg WD, Sarosy GA, Bauer KS, Davis PA, Soltis MJ, Thompkins A, Liotta LA, Reed E. Kohn EC, et al. Among authors: reed e. J Clin Oncol. 1997 May;15(5):1985-93. doi: 10.1200/JCO.1997.15.5.1985. J Clin Oncol. 1997. PMID: 9164210 Clinical Trial.

7

Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer.

Shapiro JD, Rothenberg ML, Sarosy GA, Steinberg SM, Adamo DO, Reed E, Ozols RF, Kohn EC. Shapiro JD, et al. Among authors: reed e. Cancer. 1998 Nov 1;83(9):1980-8. Cancer. 1998. PMID: 9806657 Clinical Trial.

8

Pharmacokinetics of orally administered carboxyamido-triazole, an inhibitor of calcium-mediated signal transduction.

Figg WD, Cole KA, Reed E, Steinberg SM, Piscitelli SC, Davis PA, Soltis MJ, Jacob J, Boudoulas S, Goldspiel B, et al. Figg WD, et al. Among authors: reed e. Clin Cancer Res. 1995 Aug;1(8):797-803. Clin Cancer Res. 1995. PMID: 9816048 Clinical Trial.

9

Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.

Thibault A, Samid D, Tompkins AC, Figg WD, Cooper MR, Hohl RJ, Trepel J, Liang B, Patronas N, Venzon DJ, Reed E, Myers CE. Thibault A, et al. Among authors: reed e. Clin Cancer Res. 1996 Mar;2(3):483-91. Clin Cancer Res. 1996. PMID: 9816194 Clinical Trial.

10

Pharmacokinetics and relative bioavailability of carboxyamido-triazole with respect to food and time of administration: use of a single model for simultaneous determination of changing parameters.

Bauer KS, Kohn EC, Lush RM, Steinberg SM, Davis P, Kohler D, Reed E, Figg WD. Bauer KS, et al. Among authors: reed e. J Pharmacokinet Biopharm. 1998 Dec;26(6):673-87. doi: 10.1023/a:1020750923542. J Pharmacokinet Biopharm. 1998. PMID: 10485080 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,325 results

Search Page

Filters